<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(3)</volume><submitter>He S</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Pleuropulmonary blastoma (PPB) is a rare and highly aggressive malignant tumor of the lung or pleura, primarily affecting children and closely associated with &lt;i>DICER1&lt;/i> gene mutations. Patients with type II and III PPB are prone to distant metastasis, with the central nervous system (CNS) being the most common site of metastasis, leading to a poor prognosis.&lt;h4>Case description&lt;/h4>This article provides a detailed account of the clinical manifestations, diagnostic processes, treatment plans, and follow-up outcomes of three children diagnosed with PPB accompanied by brain metastasis. Through the collaborative diagnosis and treatment by a multidisciplinary team, all three patients are currently in remission. As part of the diagnostic and treatment process, genetic test</pubmed_abstract><journal>Translational pediatrics</journal><pagination>480-486</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11983002</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Brain metastasis of pleuropulmonary blastoma: case reports.</pubmed_title><pmcid>PMC11983002</pmcid><pubmed_authors>He S</pubmed_authors><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Zhao W</pubmed_authors><pubmed_authors>Ma X</pubmed_authors><pubmed_authors>Duan C</pubmed_authors><pubmed_authors>Fu L</pubmed_authors><pubmed_authors>Yu T</pubmed_authors><pubmed_authors>Ge M</pubmed_authors><pubmed_authors>Cui C</pubmed_authors><pubmed_authors>Su Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Brain metastasis of pleuropulmonary blastoma: case reports.</name><description>&lt;h4>Background&lt;/h4>Pleuropulmonary blastoma (PPB) is a rare and highly aggressive malignant tumor of the lung or pleura, primarily affecting children and closely associated with &lt;i>DICER1&lt;/i> gene mutations. Patients with type II and III PPB are prone to distant metastasis, with the central nervous system (CNS) being the most common site of metastasis, leading to a poor prognosis.&lt;h4>Case description&lt;/h4>This article provides a detailed account of the clinical manifestations, diagnostic processes, treatment plans, and follow-up outcomes of three children diagnosed with PPB accompanied by brain metastasis. Through the collaborative diagnosis and treatment by a multidisciplinary team, all three patients are currently in remission. As part of the diagnostic and treatment process, genetic test</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-07-08T03:10:17.885Z</modification><creation>2025-07-08T03:10:17.885Z</creation></dates><accession>S-EPMC11983002</accession><cross_references><pubmed>40225067</pubmed><doi>10.21037/tp-24-341</doi></cross_references></HashMap>